|
Targeted Focal Therapy (TFT) - a term many in health
related fields may not be familiar in the context of
Prostate Cancer Treatment. This new approach can be used to
manage early stage, non-metastatic prostate cancer. At the Men’s
Health World Congress the ISMH will be opening dialogue regarding
this and other innovations in the treatment of prostate cancer.
Prof. David Crawford, Scientific Committee Member of the Men's
Health World Congress, believes, “In many countries we are winning
the war regarding eliminating advanced prostate cancer, but in some
senses loosing another war. The pendulum has swung to over diagnosis
and treatment in some men. Targeted Focal Therapy is an alternative
to more aggressive therapies in some men.” |
